Proof-of-Concept Study Shows an HIV Vaccine Can Generate Key Antibody Response in People

https://www.niaid.nih.gov/news-events/hiv-vaccine-candidate-generates-antibody-response?utm_campaign=+60667168&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term= An HIV vaccine candidate elicited trace levels of HIV broadly neutralizing antibodies and high levels of other key immune cells in an early-stage clinical trial. This immune response is an important signal that, if antibody levels can be further amplified, the vaccination strategy might be able to prevent HIV. The findings of this NIAID-supported trial were published in the journal Cell.